112 related articles for article (PubMed ID: 37979498)
1. Cyclometalated iridium(III) complexes as anti-breast cancer and anti-metastasis agents via STAT3 inhibition.
Su Y; Yang J; Wang MM; Fang HB; Liu HK; Yu ZH; Su Z
J Inorg Biochem; 2024 Feb; 251():112427. PubMed ID: 37979498
[TBL] [Abstract][Full Text] [Related]
2. Antitumor Effects of Ir(III)-2
Panchangam RL; Rao RN; Balamurali MM; Hingamire TB; Shanmugam D; Manickam V; Chanda K
Inorg Chem; 2021 Dec; 60(23):17593-17607. PubMed ID: 34767343
[TBL] [Abstract][Full Text] [Related]
3. Iridium (III) complexes induce cervical carcinoma apoptosis via disturbing cellular redox homeostasis disorder and inhibiting PI3K/AKT/mTOR pathway.
Hao J; Liu H; Wang J; Wang X; Huang C; Liang L; Chen J; Wang Y; Liu Y
J Inorg Biochem; 2022 Oct; 235():111946. PubMed ID: 35932758
[TBL] [Abstract][Full Text] [Related]
4. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
Wang J; Xu J; Xing G
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):771-779. PubMed ID: 28910973
[TBL] [Abstract][Full Text] [Related]
5. Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents.
Wu Y; Liu J; Shao M; Zhang P; Song S; Yang G; Liu X; Liu Z
J Inorg Biochem; 2022 Aug; 233():111855. PubMed ID: 35576884
[TBL] [Abstract][Full Text] [Related]
6. Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway.
Wen W; Lowe G; Roberts CM; Finlay J; Han ES; Glackin CA; Dellinger TH
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986501
[TBL] [Abstract][Full Text] [Related]
7. The cyclometalated iridium (III) complex based on 9-Anthracenecarboxylic acid as a lysosomal-targeted anticancer agent.
Liu L; Chen J; Wang MM; Huang Y; Qian Y; Xue X; Su Z; Liu HK
J Inorg Biochem; 2022 Oct; 235():111913. PubMed ID: 35905643
[TBL] [Abstract][Full Text] [Related]
8. Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer.
Bharadwaj U; Eckols TK; Kolosov M; Kasembeli MM; Adam A; Torres D; Zhang X; Dobrolecki LE; Wei W; Lewis MT; Dave B; Chang JC; Landis MD; Creighton CJ; Mancini MA; Tweardy DJ
Oncogene; 2015 Mar; 34(11):1341-53. PubMed ID: 24681959
[TBL] [Abstract][Full Text] [Related]
9. Lysosome-targeted cyclometalated iridium(III) complexes: JMJD inhibition, dual induction of apoptosis, and autophagy.
Lu JJ; Ma XR; Xie K; Chen MR; Huang B; Li RT; Ye RR
Metallomics; 2022 Sep; 14(9):. PubMed ID: 36073756
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-targeted cyclometalated iridium (III) complexes: Dual induction of A549 cells apoptosis and autophagy.
Chen L; Tang H; Chen W; Wang J; Zhang S; Gao J; Chen Y; Zhu X; Huang Z; Chen J
J Inorg Biochem; 2023 Dec; 249():112397. PubMed ID: 37844533
[TBL] [Abstract][Full Text] [Related]
11. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes.
Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ
J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin Affects STAT3/DDA1 Signaling Pathway and Reverses Breast Cancer Resistance to Cisplatin.
Zhang J; Li Y; Wang JG; Feng JY; Huang GD; Luo CG
Am J Chin Med; 2023; 51(2):445-459. PubMed ID: 36891981
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
[TBL] [Abstract][Full Text] [Related]
14. Unlocking the potential of iridium and ruthenium arene complexes as anti-tumor and anti-metastasis chemotherapeutic agents.
Lv M; Qian X; Li S; Gong J; Wang Q; Qian Y; Su Z; Xue X; Liu HK
J Inorg Biochem; 2023 Jan; 238():112057. PubMed ID: 36370504
[TBL] [Abstract][Full Text] [Related]
15. Atiprimod triggered apoptotic cell death via acting on PERK/eIF2α/ATF4/CHOP and STAT3/NF-ΚB axis in MDA-MB-231 and MDA-MB-468 breast cancer cells.
Coker-Gurkan A; Can E; Sahin S; Obakan-Yerlikaya P; Arisan ED
Mol Biol Rep; 2021 Jun; 48(6):5233-5247. PubMed ID: 34244887
[TBL] [Abstract][Full Text] [Related]
16. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ
Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753
[TBL] [Abstract][Full Text] [Related]
17. Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.
Kim SH; Nagalingam A; Saxena NK; Singh SV; Sharma D
Carcinogenesis; 2011 Mar; 32(3):359-67. PubMed ID: 21163886
[TBL] [Abstract][Full Text] [Related]
18. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
19. Platinum(IV) Complexes as Inhibitors of STAT3 and Regulators of the Tumor Microenvironment To Control Breast Cancer.
Cai L; Wang Y; Chen H; Tan Y; Yang T; Zhang S; Guo Z; Wang X
J Med Chem; 2023 Aug; 66(16):11351-11364. PubMed ID: 37578941
[TBL] [Abstract][Full Text] [Related]
20. I157172, a novel inhibitor of cystathionine γ-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3.
Wang L; Shi H; Zhang X; Zhang X; Liu Y; Kang W; Shi X; Wang T
Oncol Rep; 2019 Jan; 41(1):427-436. PubMed ID: 30365149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
